NASDAQ:AUVI - Nasdaq - US0379883004 - Common Stock - Currency: USD
0.2926
-0.03 (-8.56%)
The current stock price of AUVI is 0.2926 USD. In the past month the price decreased by -50.28%. In the past year, price decreased by -99.38%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
TT | TRANE TECHNOLOGIES PLC | 31.62 | 79.58B | ||
CARR | CARRIER GLOBAL CORP | 23.62 | 57.42B | ||
JCI | JOHNSON CONTROLS INTERNATION | 22.21 | 56.30B | ||
LII | LENNOX INTERNATIONAL INC | 27.19 | 21.84B | ||
MAS | MASCO CORP | 18.25 | 15.86B | ||
BLDR | BUILDERS FIRSTSOURCE INC | 11.91 | 15.81B | ||
CSL | CARLISLE COS INC | 16.57 | 15.18B | ||
OC | OWENS CORNING | 10.46 | 14.19B | ||
ALLE | ALLEGION PLC | 16.89 | 11.05B | ||
WMS | ADVANCED DRAINAGE SYSTEMS IN | 18.88 | 8.87B | ||
AAON | AAON INC | 45.65 | 8.42B | ||
FBIN | FORTUNE BRANDS INNOVATIONS I | 15.84 | 8.13B |
Applied UV Inc is a US-based company operating in Building Products industry. The company is headquartered in Mount Vernon, New York and currently employs 115 full-time employees. The company went IPO on 2020-08-27. Applied UV, Inc. is a sales and marketing company. The firm develops, acquires, markets, and sells surface and air disinfection technology focused on improving indoor air quality (IAQ), specialty LED lighting, luxury mirrors, and commercial furnishings, all of which serve clients globally in the healthcare, commercial & public venue, hospitality, food preservation, cannabis, education, and winery vertical markets. Its disinfectant segment is engaged in the design, manufacture, assembly, and distribution of a suite of air (fixed and mobile) and surface disinfecting systems for use in healthcare, hospitality, food preservation, education, and winery vertical markets. Its hospitality segment is engaged in the manufacture of fine mirrors and custom furniture specifically for the hospitality and retail industries. The firm has two wholly owned subsidiaries: SteriLumen, Inc., and Munn Works, LLC. SteriLumen owns and markets a portfolio of products with pathogen elimination technology.
APPLIED UV INC
150 N. Macquesten Pkwy
Mount Vernon NEW YORK 10550 US
CEO: Keyoumars Saeed
Employees: 115
Company Website: https://www.applieduvinc.com/
Phone: 19292073751
The current stock price of AUVI is 0.2926 USD. The price decreased by -8.56% in the last trading session.
The exchange symbol of APPLIED UV INC is AUVI and it is listed on the Nasdaq exchange.
AUVI stock is listed on the Nasdaq exchange.
7 analysts have analysed AUVI and the average price target is 26.78 USD. This implies a price increase of 9050.72% is expected in the next year compared to the current price of 0.2926. Check the APPLIED UV INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
APPLIED UV INC (AUVI) has a market capitalization of 490.97K USD. This makes AUVI a Nano Cap stock.
APPLIED UV INC (AUVI) currently has 115 employees.
The Revenue of APPLIED UV INC (AUVI) is expected to grow by 6.38% in the next year. Check the estimates tab for more information on the AUVI EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AUVI does not pay a dividend.
APPLIED UV INC (AUVI) will report earnings on 2024-08-12.
APPLIED UV INC (AUVI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-14.68).
ChartMill assigns a fundamental rating of 1 / 10 to AUVI. Both the profitability and financial health of AUVI have multiple concerns.
Over the last trailing twelve months AUVI reported a non-GAAP Earnings per Share(EPS) of -14.68. The EPS decreased by -107.64% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -25.38% | ||
ROE | -59.56% | ||
Debt/Equity | 0.18 |
ChartMill assigns a Buy % Consensus number of 83% to AUVI. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 38.03% and a revenue growth 6.38% for AUVI